Singapore - English - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - vonoprazan fumarate 13.36mg eqv vonoprazan - tablet, film coated - vonoprazan fumarate 13.36mg eqv vonoprazan 10mg

Singapore - English - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - vonoprazan fumarate 26.72mg eqv vonoprazan - tablet, film coated - vonoprazan fumarate 26.72mg eqv vonoprazan 20mg

United States - English - NLM (National Library of Medicine)

phathom pharmaceuticals inc. - vonoprazan fumarate (unii: 4qw3x4amlb) (vonoprazan - unii:1r5l3j156g) - voquezna triple pak or voquezna dual pak are indicated for the treatment of helicobacter pylori (h. pylori ) infection in adults [see clinical studies (14)]. to reduce the development of drug-resistant bacteria and maintain the effectiveness of voquezna triple pak, voquezna dual pak and other antibacterial drugs, voquezna triple pak and voquezna dual pak should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. hypersensitivity reactions voquezna triple pak and voquezna dual pak are contraindicated in patients with a known hypersensitivity to any component of voquezna triple pak: vonoprazan, amoxicillin (or other β-lactam antibacterials, e.g., penicillins and cephalosporins) or clari

United States - English - NLM (National Library of Medicine)

phathom pharmaceuticals inc. - vonoprazan fumarate (unii: 4qw3x4amlb) (vonoprazan - unii:1r5l3j156g) - voquezna is indicated: - for healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. - to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. - in combination with amoxicillin and clarithromycin for the treatment of helicobacter pylori (h. pylori ) infection in adults. - in combination with amoxicillin for the treatment of h. pylori infection in adults. - voquezna is contraindicated in patients with a known hypersensitivity to vonoprazan or any component of voquezna. reactions have included anaphylactic shock [see adverse reactions (6.2) and description (11)] . - voquezna is contraindicated with rilpivirine-containing products [see drug interactions (7)] . - for information about contraindications of antibacterial agents (clarithromycin and amoxicillin) indicated in combination with voquezna, refer to the contraindications section of the corresponding prescribing information.

Kenya - English - Pharmacy and Poisons Board

vonoprazan fumarate - film-coated tablet - vonoprazan 10mg - vonoprazan

Kenya - English - Pharmacy and Poisons Board

vonoprazan fumarate - film-coated tablet - vonoprazan 20 mg - vonoprazan

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

takeda malaysia sdn bhd - vonoprazan fumarate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

takeda malaysia sdn bhd - vonoprazan fumarate -

Kenya - English - Pharmacy and Poisons Board

q pharma dmcc unit no: 2681 dmcc business centre level no. 1 - vonoprazan fumarate - coated tablet - vonoprazan fumarate 10mg - drugs for peptic ulcer and gastro-oesophageal

Kenya - English - Pharmacy and Poisons Board

unit no: 2681 dmcc business centre level no. 1… unit no: 2681 dmcc business centre level no. 1 - vonoprazan fumarate - coated tablet - vonoprazan fumarate 20mg - drugs for peptic ulcer and gastro-oesophageal